Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial - Boer, SM; Powell, ME; Mileshkin, L (Lancet Oncol, 2018)